Literature DB >> 15322933

Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

V Verhoeven1, M Baay, J Weyler, D Avonts, F Lardon, P Van Royen, J B Vermorken.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15322933     DOI： 10.1007/s10096-004-1194-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  19 in total

1.  Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

Authors:  T Anttila; P Saikku; P Koskela; A Bloigu; J Dillner; I Ikäheimo; E Jellum; M Lehtinen; P Lenner; T Hakulinen; A Närvänen; E Pukkala; S Thoresen; L Youngman; J Paavonen
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

2.  HPV in cervix and vagina.

Authors:  M Baay; F Lardon; J B Vermorken; V Verhoeven; D Avonts; P Van Royen; K Wouters; P Van Damme; E Van Marck
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

3.  Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.

Authors:  P Hillemanns; R Kimmig; U Hüttemann; C Dannecker; C J Thaler
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

4.  Incidence, clearance and predictors of human papillomavirus infection in women.

Authors:  John W Sellors; Tina L Karwalajtys; Janusz Kaczorowski; James B Mahony; Alice Lytwyn; Sylvia Chong; Joanna Sparrow; Attila Lorincz
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262

5.  Risk factors for HPV DNA detection in middle-aged women.

Authors:  N Muñoz; I Kato; F X Bosch; J Eluf-Neto; S De Sanjosé; N Ascunce; M Gili; I Izarzugaza; P Viladiu; M J Tormo; P Moreo; L C Gonzalez; L Tafur; J M Walboomers; K V Shah
Journal:  Sex Transm Dis       Date:  1996 Nov-Dec       Impact factor: 2.830

6.  The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.

Authors:  Servaas A Morré; Adriaan J C van den Brule; Lawrence Rozendaal; A Joan P Boeke; Feja J Voorhorst; Sjoerd de Blok; Chris J L M Meijer
Journal:  Int J STD AIDS       Date:  2002-12       Impact factor: 1.359

7.  Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk.

Authors:  P K Jha; V Beral; J Peto; S Hack; C Hermon; J Deacon; D Mant; C Chilvers; M P Vessey; M C Pike
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

8.  Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis.

Authors:  Hala Tamim; Ramzi R Finan; Huda E Sharida; Mooza Rashid; Wassim Y Almawi
Journal:  Diagn Microbiol Infect Dis       Date:  2002-08       Impact factor: 2.803

9.  Chlamydial infection: an accurate model for opportunistic screening in general practice.

Authors:  V Verhoeven; D Avonts; A Meheus; H Goossens; M Ieven; S Chapelle; C Lammens; P Van Royen
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

10.  Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis.

Authors:  Julius Schachter; William M McCormack; Max A Chernesky; David H Martin; Barbara Van Der Pol; Peter A Rice; Edward W Hook; Walter E Stamm; Thomas C Quinn; Joan M Chow
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948
View more
  3 in total

1.  Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.

Authors:  Loris Y Hwang; Yifei Ma; Stephen C Shiboski; Sepideh Farhat; Janet Jonte; Anna-Barbara Moscicki
Journal:  J Infect Dis       Date:  2012-06-13       Impact factor: 5.226

2.  Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology.

Authors:  Donatella Panatto; Daniela Amicizia; Silvia Bianchi; Elena Rosanna Frati; Carla Maria Zotti; Piero Luigi Lai; Alexander Domnich; Daniela Colzani; Roberto Gasparini; Elisabetta Tanzi
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda.

Authors:  Nienke J Veldhuijzen; Sarah L Braunstein; Joseph Vyankandondera; Chantal Ingabire; Justin Ntirushwa; Evelyne Kestelyn; Coosje Tuijn; Ferdinand W Wit; Aline Umutoni; Mireille Uwineza; Tania Crucitti; Janneke H H M van de Wijgert
Journal:  BMC Infect Dis       Date:  2011-12-02       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.